» Articles » PMID: 18678783

Evidence Mandating Earlier and More Aggressive Treatment of Hypercholesterolemia

Overview
Journal Circulation
Date 2008 Aug 6
PMID 18678783
Citations 24
Authors
Affiliations
Soon will be listed here.
Citing Articles

Safety and efficacy of PCSK9 inhibitor (evolocumab) in patients with non-ST segment elevation acute coronary syndrome and non-culprit artery critical lesions: a randomised controlled trial protocol (SPECIAL study).

Wang Y, Xu J, Ma L, Hu H, Chen H, Hua J BMJ Open. 2024; 14(7):e083730.

PMID: 39009458 PMC: 11253731. DOI: 10.1136/bmjopen-2023-083730.


Lipid Profile in Olympic Athletes: Proposal for a "Lipid Athlete Score" as a Clinical Tool to Identify High-Risk Athletes.

Di Gioia G, Buzzelli L, Maestrini V, Nenna A, Monosilio S, Squeo M J Clin Med. 2023; 12(23).

PMID: 38068500 PMC: 10707559. DOI: 10.3390/jcm12237449.


Endometriosis promotes atherosclerosis in a murine model.

Mamillapalli R, Toffoloni N, Habata S, Qunhua H, Atwani R, Stachenfeld N Am J Obstet Gynecol. 2022; 227(2):248.e1-248.e8.

PMID: 35351413 PMC: 9308711. DOI: 10.1016/j.ajog.2022.03.040.


Mouse models of atherosclerosis and their suitability for the study of myocardial infarction.

Golforoush P, Yellon D, Davidson S Basic Res Cardiol. 2020; 115(6):73.

PMID: 33258000 PMC: 7704510. DOI: 10.1007/s00395-020-00829-5.


AIBP protects against metabolic abnormalities and atherosclerosis.

Schneider D, Choi S, Agatisa-Boyle C, Zhu L, Kim J, Pattison J J Lipid Res. 2018; 59(5):854-863.

PMID: 29559522 PMC: 5928435. DOI: 10.1194/jlr.M083618.